CMS Releases FY 2019 IPPS and PTCH PPS Proposed Rule
Recently, the Centers for Medicare & Medicaid Services (CMS) released its fiscal year (FY) 2019 inpatient prospective payment…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2018
FDA Publishes Draft Guidance on Expanding 510(k) Pathway
A draft guidance recently issued by the United States Food and Drug Administration (FDA) sets the stage for how an existing 510(k)…
Azar Continues to Promote Administration Drug Pricing Policy, Plus RFI…
On June 26, 2018, the Senate Finance Committee held a hearing to examine President Donald Trump’s plan to lower prescription drug…
Open Payments Data 2017: Significant Drop in Number of Payments
On Friday, June 29, 2018 the Centers for Medicare & Medicaid Services (“CMS”) released the 2017 Open Payments Data, which…
New Jersey Court Disallows OptumRx PBM Contract
In May 2018, a New Jersey appeals court threw out a $6.7 billion contract between the state and OptumRx for prescription drug…
CMS Seeking Input on Stark Law Regulatory Impact and Burden
Recently, on June 20, 2018, the United States Center for Medicare and Medicaid Services (CMS) issued a Request for Information…
Pharmacy Benefit Managers: States Put the Middlemen on the Run –…
As the federal government continues talking on ways it could address drug costs for tomorrow, state legislatures are acting to…
House Passes Sweeping Bi-Partisan Opioid Legislation CBO Outlines the Cost
Late last week, the US House of Representatives passed a series of bipartisans bills and combined them into one large bill to…
FDA Prepares for OND Modernization
On Friday, May 4, 2018, United States Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, discussed plans to…
Health Canada Takes on Opioid Transparency – Notice of Intent to…
In the United States, the need for transparency when it comes to prescribing opioids has been a topic of discussion for months…